Effect of Sarcopenia on 10-Year Risk of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus

References

• Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O, Wright JM. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548. doi:10.1371/journal.pone.0169548
   PubMed Web of Science ®Google Scholar
• Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S–991S. doi:10.1093/jn/127.5.990S
   PubMed Web of Science ®Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–763. doi:10.1093/oxfordjournals.aje.a009520
   PubMed Web of Science ®Google Scholar
• Filippin LI, Teixeira VN, da Silva MP, Miraglia F, da Silva FS. Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention. Aging Clin Exp Res. 2015;27(3):249–254. doi:10.1007/s40520-014-0281-4
   Web of Science ®Google Scholar
• Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48(1):48–56. doi:10.1093/ageing/afy106
   PubMed Web of Science ®Google Scholar
• Ethgen O, Beaudart C, Buckinx F, Bruyere O, Reginster JY. The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int. 2017;100(3):229–234. doi:10.1007/s00223-016-0220-9
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabet Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Briggs AM, Woolf AD, Dreinhofer K, et al. Reducing the global burden of musculoskeletal conditions. Bull World Health Organ. 2018;96(5):366–368. doi:10.2471/BLT.17.204891
   PubMed Web of Science ®Google Scholar
• St-Onge MP, Gallagher D. Body composition changes with aging: the cause or the result of alterations in metabolic rate and macronutrient oxidation? Nutrition. 2010;26(2):152–155. doi:10.1016/j.nut.2009.07.004
   PubMed Web of Science ®Google Scholar
• Hong S, Chang Y, Jung HS, Yun KE, Shin H, Ryu S. Relative muscle mass and the risk of incident type 2 diabetes: a cohort study. PLoS One. 2017;12(11):e0188650. doi:10.1371/journal.pone.0188650
   PubMed Web of Science ®Google Scholar
• Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81(3):555–563. doi:10.1093/ajcn/81.3.555
   PubMed Web of Science ®Google Scholar
• Wong E, Backholer K, Gearon E, et al. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013;1(2):106–114.
   Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795–808. doi:10.1016/S0140-6736(19)32008-2
   PubMed Web of Science ®Google Scholar
• Gao K, Cao LF, Ma WZ, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264. doi:10.1016/j.eclinm.2021.101264
   Google Scholar
• He N, Zhang Y, Zhang L, Zhang S, Ye H. Relationship between sarcopenia and cardiovascular diseases in the elderly: an overview. Front Cardiovasc Med. 2021;8:743710. doi:10.3389/fcvm.2021.743710
   Web of Science ®Google Scholar
• Sasaki KI, Kakuma T, Sasaki M, et al. The prevalence of sarcopenia and subtypes in cardiovascular diseases, and a new diagnostic approach. J Cardiol. 2020;76(3):266–272.
   Web of Science ®Google Scholar
• Lim HS, Park YH, Suh K, et al. Association between sarcopenia, sarcopenic obesity, and chronic disease in Korean elderly. J Bone Metab. 2018;25(3):187–193. doi:10.11005/jbm.2018.25.3.187
   Google Scholar
• Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010;33(7):1652–1654. doi:10.2337/dc10-0107
   PubMed Web of Science ®Google Scholar
• Yang X, Li J, Hu D, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016;134(19):1430–1440. doi:10.1161/CIRCULATIONAHA.116.022367
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Mauer SM. Structural-functional correlations of diabetic nephropathy. Kidney Int. 1994;45(2):612–622. doi:10.1038/ki.1994.80
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819–829. doi:10.1016/S2213-8587(14)70034-8
   PubMed Web of Science ®Google Scholar
• Yang XL, Chen JC, Li JX, et al. Risk stratification of atherosclerotic cardiovascular disease in Chinese adults. Chronic Dis Transl Med. 2016;2(2):102–109. doi:10.1016/j.cdtm.2016.10.001
   Google Scholar
• Umegaki H. Sarcopenia and frailty in older patients with diabetes mellitus. Geriatr Gerontol Int. 2016;16(3):293–299. doi:10.1111/ggi.12688
   PubMed Web of Science ®Google Scholar
• Wang M, Tan Y, Shi Y, Wang X, Liao Z, Wei P. Diabetes and sarcopenic obesity: pathogenesis, diagnosis, and treatments. Front Endocrinol. 2020;11:568. doi:10.3389/fendo.2020.00568
   PubMed Web of Science ®Google Scholar
• Hida T, Imagama S, Ando K, et al. Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: the Yakumo study. Mod Rheumatol. 2018;28(2):345–350. doi:10.1080/14397595.2017.1349058
   PubMed Web of Science ®Google Scholar
• Dos Santos MR, Saitoh M, Ebner N, et al. Sarcopenia and endothelial function in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF). J Am Med Dir Assoc. 2017;18(3):240–245. doi:10.1016/j.jamda.2016.09.006
   PubMed Web of Science ®Google Scholar
• Park SJ, Ryu SY, Park J, Choi SW. Association of sarcopenia with metabolic syndrome in Korean population using 2009–2010 Korea National Health and Nutrition Examination Survey. Metab Syndr Relat Disord. 2019;17(10):494–499. doi:10.1089/met.2019.0059
   PubMed Web of Science ®Google Scholar
• Park S, Ham JO, Lee BK. A positive association between stroke risk and sarcopenia in men aged >/= 50 years,but not women: results from the Korean National Health and Nutrition Examination Survey 2008–2010. J Nutr Health Aging. 2014;18(9):806–812. doi:10.1007/s12603-014-0553-x
   Web of Science ®Google Scholar
• Zeng F, Huang L, Zhang Y, et al. Additive effect of sarcopenia and anemia on the 10-year risk of cardiovascular disease in patients with type 2 diabetes. J Diabetes Res. 2022;2022:2202511. doi:10.1155/2022/2202511
   Web of Science ®Google Scholar
• Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest. 2013;36(7):537–543. doi:10.3275/8943
   PubMed Web of Science ®Google Scholar
• Karcher HS, Holzwarth R, Mueller HP, et al. Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study. Cerebrovasc Dis. 2013;35(4):341–348. doi:10.1159/000348703
   Web of Science ®Google Scholar
• Song MY, Ruts E, Kim J, Janumala I, Heymsfield S, Gallagher D. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr. 2004;79(5):874–880. doi:10.1093/ajcn/79.5.874
   PubMed Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48. doi:10.1161/CIRCULATIONAHA.106.675355
   PubMed Web of Science ®Google Scholar
• Bellanti F, Romano AD, Lo Buglio A, et al. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity. Maturitas. 2018;109:6–12. doi:10.1016/j.maturitas.2017.12.002
   PubMed Web of Science ®Google Scholar
• Sanada K, Miyachi M, Tanimoto M, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57–65. doi:10.1007/s00421-010-1473-z
   PubMed Web of Science ®Google Scholar